James G. Marken - 28 Feb 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP OPS & PROD DEV
Signature
/s/ James G. Marken, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
28 Feb 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 20:06:06 UTC
Previous filing
16 Aug 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Award $0 +13,026 +12% $0.000000 125,232 28 Feb 2023 Direct F1
transaction ANIP Common Stock Award $0 +8,684 +6.9% $0.000000 133,916 28 Feb 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023.
F2 These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Remarks:

Exhibit 24 - Power of Attorney